Steven J. Pelch
CIK 1596211 · COO & Exec VP Org Plan & Dev · last filed 2020-12-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
EMR price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
8000 W. FLORISSANT AVENUE
ST. LOUIS, MO 63136
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EMR | COO & Exec VP Org Plan & Dev | 159,366 | $171.16 | $27.28M | -$1.45M | 16 | 2020-12-03 |
Recent Filings · Page 2 of 2
16 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-02-13 | EMR | Mixed | — | -$75.7K | EDGAR |
| 2016-11-03 | EMR | Grant (A) | +17,379 | $0 | EDGAR |
| 2016-03-23 | EMR | Gift (G) | −300 | $0 | EDGAR |
| 2015-11-05 | EMR | Grant (A) | +15,000 | $0 | EDGAR |
| 2014-12-23 | EMR | Mixed | +572 | $43 | EDGAR |
| 2014-10-02 | EMR | Mixed | +4,462 | -$140.2K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.